EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Hepatoblastoma with spindle cell sarcomatous metastasis in a 14-year-old girl

Yanting Zhang, Xuedi Yu, Junjie Ge, Jingjing Wang, Chuanfeng Bai, Suyi Kang, Jingfu Wang

Frontiers in Pediatrics · 12.03.2026 · 14

DOI: 10.3389/fped.2026.1773950 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Pediatrics, online erschienen am 12.03.2026. Verfasst von Yanting Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences,…. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatoblastoma (HB) is the most common pediatric liver malignancy and occurs predominantly in children younger than 5 years of age. We report the case of a 14-year-old girl who was diagnosed with mixed epithelial–mesenchymal hepatoblastoma without any metastases. Initial evaluation revealed a markedly elevated serum alpha-fetoprotein level (7,800 ng/mL) and a large hepatic mass (17.3 cm × 18.4 cm × 8.5 cm) in the left liver lobe on contrast-enhanced CT. The patient underwent surgical resection, and pathological examination confirmed mixed epithelial–mesenchymal HB. Postoperative chemotherapy (consisting of cisplatin, doxorubicin, and 5-FU) normalized serum alpha-fetoprotein levels; however, skull metastasis developed during treatment. Histopathological analysis of the metastatic lesion revealed spindle cell sarcoma with decreased GPC-3/Hepa expression and elevated CD34/Ki-67 expression. Multiple chemotherapy regimens (ifosfamide, carboplatin, and etoposide; and doxorubicin, vincristine, cyclophosphamide, and cisplatin) demonstrated limited efficacy. Subsequent treatment with alternating albumin-paclitaxel, gemcitabine, ifosfamide, and etoposide/cyclophosphamide, irinotecan, and vincristine chemotherapy combined with anlotinib and cranial radiotherapy achieved disease stabilization, with no subsequent progression observed during follow-up. This case highlights the aggressive nature and chemoresistance of the mesenchymal components of HB, emphasizing the need for novel therapeutic approaches that incorporate targeted agents.

Schlagwörter

Stichwörter der Autor:innen

alpha-fetoproteinchemotherapyhepatoblastomametastasisspindle cell sarcoma

Autor:innen und Institutionen

  • Department of Pediatric Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.

Zitieren

APA

Zhang, Y., Yu, X., Ge, J., Wang, J., Bai, C., Kang, S., & Wang, J. (2026). Case Report: Hepatoblastoma with spindle cell sarcomatous metastasis in a 14-year-old girl. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1773950

Vancouver

Zhang Y, Yu X, Ge J, Wang J, Bai C, Kang S, et al. Case Report: Hepatoblastoma with spindle cell sarcomatous metastasis in a 14-year-old girl. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1773950

BibTeX
@article{Zhang2026,
  author = {Zhang, Yanting and Yu, Xuedi and Ge, Junjie and Wang, Jingjing and Bai, Chuanfeng and Kang, Suyi and Wang, Jingfu},
  title = {Case Report: Hepatoblastoma with spindle cell sarcomatous metastasis in a 14-year-old girl},
  journal = {Frontiers in Pediatrics},
  year = {2026},
  volume = {14},
  doi = {10.3389/fped.2026.1773950}
}
Kostenlos starten →